Navigation Links
Partnership Brings Breast Image Documentation Technology to Women Around the World
Date:7/13/2010

LOS ANGELES, July 13 /PRNewswire/ -- Medical Tactile, Inc. and Valentus Medical Technologies, Inc. announced today that Valentus Medical Technologies, Inc., based in Victoria, Canada, has signed a partnership agreement with Medical Tactile, Inc., and has taken on the exclusive Sales & Marketing rights for SureTouch™, the non-invasive digital breast imaging technology, worldwide, with the exception of China.

"Valentus has made a significant investment in Medical Tactile that will greatly assist us in advancing research and development for this important technology," said Jae Son, Chairman of Medical Tactile, Inc.  "Valentus brings a health and wellness clinic-based approach to help bring SureTouch™ to market in North America as well as grow existing international markets."

"We are excited about the partnership with MTI and are thrilled to be able to bring SureTouch™ technology to women of all ages around the world," said Stephen L. Davis, CEO of Valentus Medical Technologies, Inc.  "Nearly 45,000 women in North America alone will die from breast cancer in 2010, and the incidence of breast cancer in some developing countries is rising at a rate of up to 5% per year.  When breast cancer is found and treated early, when it is small, chances are better that it can be successfully removed and mortality can be reduced.  We believe that women deserve to have access to SureTouch™ technology and we hope to contribute to saving more lives by enhancing the Clinical Breast Exam (CBE) procedure with the improved documentation SureTouch™ technology provides."

SureTouch™ has FDA clearance and enhances the routine Clinical Breast Exam using Tactile or Palpation Imaging technology.  It is an accurate, non-invasive (uses no radiation), comfortable, and affordable breast image documentation device.  It measures the reactive pressures generated by a breast lesion, which can be as much as 100 times harder than normal tissue and may prove to be cancerous. It documents the shape, location, hardness and size of breast lesions. SureTouch™ is compact, portable and easy to set up. Training for physicians and other clinicians will be offered online.

About Valentus Medical Technologies, Inc.

Valentus Medical Technologies, Inc. (VMT) is a Victoria, Canada based provider of accurate, affordable, approved and easy to use medical devices that enhance the integrity of diagnosis and provide low cost accessibility to patients in order to improve their personal health and well-being.  VMT is owned and operated by Valentus Health Clinics, Inc., a leading health service practitioner, committed to improving people's health through the use of innovative, proven and non-invasive technologies.

About Medical Tactile, Inc.

Medical Tactile, Inc., is a leading developer of tactile sensor technologies for the detection and assessment of cancer and other diseases of the breast.  Medical Tactile's mission is to improve the quality and cost-effectiveness of healthcare services in this area.


'/>"/>
SOURCE Valentus Medical Technologies, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
2. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
3. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
4. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
5. iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
6. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
7. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
8. iCAD Initiates Clinical Study of Its Virtual Colonoscopy CAD in Partnership with ACR Image Metrix
9. AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds
10. Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig
11. Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... - Medicure Inc. ("Medicure") (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical ... ended December 31, 2016 after market close on ... released later than the previous fiscal year,s results ... and balances of Apicore from the acquisition date ... date meets TSX Venture Exchange listed company requirements. ...
(Date:3/28/2017)... 28, 2017 "Chemotherapy Induced Neutropenia (CIN) – Market Insights, ... and global market trends of the Chemotherapy Induced Neutropenia for the ... Europe ( France , ... , UK) and Japan , as well ... of the world (RoW). The Report covers the therapeutics ...
(Date:3/28/2017)... March 28, 2017  "US Cancer Generics Market ... various indicators and trend analysis related to the ... mainstream pharmaceutical market in US. The report analyzes ... growth on cancer generics drugs in recent years. ... of billions of dollars for various stake holders ...
Breaking Medicine Technology:
(Date:3/29/2017)... ... March 29, 2017 , ... ... without a referral to new patients from Burnaby, BC. Patients in need of ... mouth reconstruction services, can see the esteemed team at Wall Centre Dental. Drs. ...
(Date:3/29/2017)... ... 2017 , ... Patients interested in receiving quick and effective ... Cameron, with or without a referral. The FASTBRACES system is valued for its ... patient’s case, treatment with the FASTBRACES system could be completed in 120 days ...
(Date:3/29/2017)... ... March 29, 2017 , ... ... continues developing an ANSI-approved, consensus-based American National Standard for Good Manufacturing Practices ... the first ANSI-approved GMP standard for dietary supplements this spring, is hiring ...
(Date:3/29/2017)... ... 29, 2017 , ... Altima Technologies, Inc., the maker of ... center assets and audio-video devices has recently updated its Visio Stencils library with ... and download shapes and stencils from http://www.VisioStencils.com. , New devices were ...
(Date:3/29/2017)... PITTSBURGH, PA (PRWEB) , ... March 29, 2017 ... ... and hassles associated with wearing oral braces. "The rubber bands used in conjunction ... he said, "so I decided to design a way to prevent this problem." ...
Breaking Medicine News(10 mins):